<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART)</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2005-05-18">18 May 2005</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">François-Jérôme</forename><surname>Authier</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Patrick</forename><surname>Chariot</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Faculte ´de Me ´decine</orgName>
								<orgName type="institution" key="instit1">INSERM</orgName>
								<orgName type="institution" key="instit2">Universite ´Paris 12</orgName>
								<address>
									<addrLine>Cre ´teil</addrLine>
									<postCode>E0011</postCode>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Romain</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">De ´partement de Pathologie</orgName>
								<orgName type="institution">Ho ˆpital Henri-Mondor</orgName>
								<address>
									<addrLine>Cre ´teil</addrLine>
									<postCode>F-94010</postCode>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Faculte ´de Me ´decine</orgName>
								<orgName type="institution" key="instit1">INSERM</orgName>
								<orgName type="institution" key="instit2">Universite ´Paris 12</orgName>
								<address>
									<addrLine>Cre ´teil</addrLine>
									<postCode>E0011</postCode>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART)</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Muscle &amp; Nerve</title>
						<title level="j" type="abbrev">Muscle Nerve</title>
						<idno type="ISSN">0148-639X</idno>
						<idno type="eISSN">1097-4598</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">32</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page" from="247" to="260"/>
							<date type="published" when="2005-05-18">18 May 2005</date>
						</imprint>
					</monogr>
					<idno type="MD5">A78B3BBD595C4D910FFBB80A77B77148</idno>
					<idno type="DOI">10.1002/mus.20338</idno>
					<note type="submission">Accepted 24 February 2005</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CDC, Centers for Disease Control</term>
					<term>CK, creatine kinase</term>
					<term>CMV, cytomegalovirus</term>
					<term>COX, cytochrome c oxidase</term>
					<term>DILS, diffuse infiltrative lymphocytosis syndrome</term>
					<term>EMG, electromyogram</term>
					<term>FIV, feline immunodeficiency virus</term>
					<term>HAART, highly active antiretroviral therapy</term>
					<term>HAM, HTLV-I-associated myelopathy</term>
					<term>HHV, human herpesvirus</term>
					<term>HIV, human immunodeficiency virus</term>
					<term>HMG-CoA, hydroxymethylglutaryl-coenzyme A</term>
					<term>HTLV-I, human T-cell lymphotropic virus type I</term>
					<term>IBM, inclusion-body myositis</term>
					<term>IL, interleukin</term>
					<term>IRIS, immune restoration inflammatory syndrome</term>
					<term>LBM, lean body mass</term>
					<term>MG, myasthenia gravis</term>
					<term>MHC, major histocompatibility complex</term>
					<term>mt, mitochondrial</term>
					<term>nSREBP, nuclear sterol regulatory element binding protein</term>
					<term>NRTI, nucleosideanalogue reverse-transcriptase inhibitor</term>
					<term>PI, protease inhibitor</term>
					<term>PM, polymyositis</term>
					<term>SIV, simian immunodeficiency virus</term>
					<term>SRV, simian retrovirus</term>
					<term>TCR, T-cell receptor</term>
					<term>TNF, tumor necrosis factor</term>
					<term>TSP, tropical spastic paraparesis acquired immunodeficiency syndrome (AIDS)</term>
					<term>HAART</term>
					<term>human immunodeficiency virus (HIV)</term>
					<term>immune restoration</term>
					<term>lipodystrophy</term>
					<term>mitochondria</term>
					<term>myasthenia</term>
					<term>myopathy</term>
					<term>polymyositis</term>
					<term>rhabdomyolysis</term>
					<term>skeletal muscle</term>
					<term>vasculitis</term>
					<term>wasting</term>
					<term>zidovudine</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Skeletal muscle involvement can occur at all stages of human immunodeficiency virus (HIV) infection, and may represent the first manifestation of the disease. Myopathies in HIV-infected patients are classified as follows: (1) HIV-associated myopathies and related conditions, including HIV polymyositis, inclusion-body myositis, nemaline myopathy, diffuse infiltrative lymphocytosis syndrome (DILS), HIV-wasting syndrome, vasculitic processes, myasthenic syndromes, and chronic fatigue; (2) muscle complications of antiretroviral therapy, including zidovudine and toxic mitochondrial myopathies related to other nucleoside-analogue reversetranscriptase inhibitors (NRTIs), HIV-associated lipodystrophy syndrome, and immune restoration syndrome related to highly active antiretroviral therapy (HAART); (3) opportunistic infections and tumor infiltrations of skeletal muscle; and (4) rhabdomyolysis. Introduction of HAART has dramatically modified the natural history of HIV disease by controlling viral replication, but, in turn, lengthening of the survival of HIV-infected individuals has been associated with an increasing prevalence of iatrogenic conditions.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>fected individual survival, HAART was increasingly found to cause a new iatrogenic condition, called the lipodystrophy syndrome. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b22">23</ref> Although the impact of HAART on the prevalence of muscle involvement was not firmly established by epidemiological studies, <ref type="bibr" target="#b91">92</ref> such an impact seems quite likely in practice, as suggested by the marked decrease of muscle biopsies performed in HIV-infected individuals in French neuromuscular centers since 1998. However, the whole spectrum of previously described muscular complications of HIV infection is still occasionally observed, especially in patients without treatment. Lack of treatment may be due to previously undiagnosed HIV infection, drug withdrawal after an adverse reaction, or unavailability of appropriate therapy for patients originating from developing countries.</p><p>Skeletal muscle involvement may occur at all stages of HIV infection and may be classified as follows: (1) HIV-associated myopathies and related conditions; (2) muscle complications of antiretroviral therapy; (3) opportunistic infections and tumor infiltrations of skeletal muscle; and (4) rhabdomyolysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HIV-ASSOCIATED MYOPATHY AND RELATED CONDITIONS</head><p>HIV Polymyositis. HIV-associated myopathy can occur at any stage of HIV infection <ref type="bibr" target="#b83">84</ref> and may reveal the underlying infection. <ref type="bibr" target="#b45">46</ref> The clinical and histopathological features are basically similar to those of polymyositis (PM) in seronegative individuals. <ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b79">80</ref> It is characterized by proximal and often symmetric muscle weakness that develops subacutely, over weeks to months, without cutaneous rash or involvement of the extraocular and facial muscles. <ref type="bibr" target="#b41">42</ref> Myalgias seem more frequent than in seronegative PM patients. <ref type="bibr" target="#b83">84</ref> The electromyogram (EMG) typically shows short-duration polyphasic motor unit potentials and abnormal spontaneous activity, but a number of patients have a normal EMG. <ref type="bibr" target="#b83">84</ref> Serum creatine kinase (CK) levels are more often increased, but without correlation with disease severity. <ref type="bibr" target="#b83">84</ref> Muscle biopsy is the definitive test for establishing the diagnosis of PM and excluding other conditions. It typically shows the characteristic triad of scattered necrotic and basophilic fibers, multiple foci of mononuclear inflammatory cells within fascicles, and focal invasion of non-necrotic muscle fibers by inflammatory cells. Most often, the lesions are less well defined and include rare necrotic fibers and inflammatory infiltrates, without a clear focal attack on muscle fibers. Immunohistochemistry is neces-sary to provide evidence of the polymyositic process. The immunohistological profile of PM includes: (1)  endomysial infiltrates of activated CD8 ϩ T cells (Fig. <ref type="figure" target="#fig_0">1A</ref>); (2) ubiquitous sarcolemmal expression of MHC class I antigens by muscle fibers (Fig. <ref type="figure" target="#fig_0">1B</ref>); and (3) focal invasion of non-necrotic fibers expressing MHC-I by CD8 ϩ T cells, a condition termed "MHC-I/CD8 complex." <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b79">80,</ref><ref type="bibr" target="#b132">133</ref> The presence of CD8/ MHC-I complex at histopathological examination is required to confirm the diagnosis of PM. <ref type="bibr" target="#b42">43</ref> In addition, histological signs of HIV-associated PM may be intermingled with those of zidovudine myopathy, as discussed in what follows. On the borders of HIV polymyositis, necrotizing myopathies, without inflammation, which may <ref type="bibr" target="#b136">137</ref> or may not <ref type="bibr" target="#b109">110</ref> be associated with recurrent myoglobinuria, have been described. Granulomatous myositis with multinucleated giant-cell formation has also been reported in rare HIV-infected individuals. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b58">59</ref> The significance of multinucleated giant cells is unknown, but their presence is reminiscent of the HIV-associated multinucleated giant cells that have been described in brain <ref type="bibr" target="#b68">69</ref> and, much more rarely, outside the central nervous system. <ref type="bibr" target="#b67">68</ref> Treatment of HIV-associated PM is similar to that of PM in non-HIV patients and remains rather empirical. <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b83">84</ref> Agents used in the treatment of PM include corticosteroids, azathioprine, methotrexate, cyclophosphamide, cyclosporine, and intravenous immunoglobulins (IVIg). In patients with muscle weakness, prednisone at a dose of 1 mg/kg is usually the first-line drug, but its prolonged administration could favor emergence of opportunistic infections. <ref type="bibr" target="#b83">84</ref> Pulse intravenous methylprednisolone has been proposed to reduce immunosuppression. Low-dose oral methotrexate (7.5 mg weekly) and azathioprine (150 mg/day) can be used without major adverse effect in HIV-infected patients. <ref type="bibr" target="#b83">84</ref> Mycophenolate mofetil is a promising, well-tolerated drug, <ref type="bibr" target="#b92">93</ref> but its place in the treatment of HIV PM needs to be delineated. Nonsteroidal anti-inflammatory drugs may be used with good response in patients without demonstrable evidence of muscle weakness but complaining of myalgias. <ref type="bibr" target="#b83">84</ref> From a pathophysiological perspective, elementary mechanisms leading to myofiber injury are the same in both HIV PM and idiopathic/primary PM. MHC-I/CD8 complex assesses the existence of an antigen-directed cytotoxicity mediated by CD8 ϩ cytotoxic T cells. <ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b42">43</ref> This conclusion is supported by the presence of CD8 ϩ cells that initially surround and eventually invade and destroy healthy, nonnecrotic, muscle fibers that aberrantly express MHC-I molecules. <ref type="bibr" target="#b42">43</ref> In PM, CD8 ϩ T cells were found to be clonally expanded in both the circulation and muscle tissue. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b104">105</ref> Interestingly, in diseased muscle, clonal expansion is restricted to autoinvasive T cells. <ref type="bibr" target="#b15">16</ref> When performed, molecular analysis of the T-cell receptor (TCR) CDR3 region of such invasive CD8 ϩ T cells showed the presence of conserved amino acid sequences suggestive of an antigendriven T-cell expansion <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b104">105</ref> ; such an antigen, possibly an autoantigen, remains undetermined. To be effective, CD8 ϩ T-cell-mediated cytotoxicity requires expression of both MHC-I antigens and costimulatory molecules by target cells. Adult myofiber is one of the few cell types that does not constitutively express MHC-I in the normal state, and aber-rant widespread MHC-I expression by myofibers is a striking feature of PM. During regeneration, MHC-I is expressed only by myoblasts, and interferon-␥ induces MHC-I in regenerating but not mature myofibers. <ref type="bibr" target="#b110">111</ref> Transgenic mice overexpressing MHC-I in muscle tissue develop an inflammatory myopathy, but their histopathological features seem distinct from those of typical PM. <ref type="bibr" target="#b103">104</ref> In addition to MHC-I, muscle cells express costimulatory molecules, BB-1 and ICOS (inducible costimulator), and their ligands, CD28/CTLA-4 and LICOS, are upregulated on autoinvasive CD8 ϩ T cells, generating possible cytotoxicity. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b42">43</ref> Accordingly, invasive CD8 ϩ T cells contain perforin and granzyme granules located to- ward the target muscle fibers, <ref type="bibr" target="#b63">64</ref> with the perforin pathway appearing to be the major cytotoxic effector pathway in PM. <ref type="bibr" target="#b42">43</ref> Postnecrosis myofiber regeneration results from activation of myogenic precursor cells residing beneath the muscle-fiber basal lamina, the so-called satellite cells. <ref type="bibr" target="#b75">76</ref> Once activated, myogenic precursor cells, which are located close to capillaries, initiate monocyte recruitment, and macrophages recruited at the injury site actively remove necrotic debris to facilitate subsequent muscle regeneration. <ref type="bibr" target="#b35">36</ref> However, in PM, T-cell infiltrates may be an impediment to muscle repair because T-cell-derived cytokine interferon-␥ hinders fiber regeneration in addition to upregulating MHC-I expression, and therefore contributes to perpetuation of injury.</p><p>The direct role of virus in the HIV-associated PM process remains unclear. <ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b83">84,</ref><ref type="bibr" target="#b87">88</ref> Various retroviruses other than HIV have been associated with PM in humans, monkeys, and cats. <ref type="bibr" target="#b86">87,</ref><ref type="bibr" target="#b100">101,</ref><ref type="bibr" target="#b112">113</ref> Neither viral replication nor genome has been detected within muscle fibers, except once, <ref type="bibr" target="#b119">120</ref> whereas HIV sequences and antigens are commonly detected in endomysial macrophages or lymphocytes. <ref type="bibr" target="#b83">84</ref> Such a discrepancy between the clinical evidence for a pathogenic role for HIV and its absence from the target cells suggests that HIV-associated PM is one of the autoimmune manifestations of HIV infection. <ref type="bibr" target="#b61">62</ref> Autoimmunity must be considered as a part of HIVinfection immunopathogenesis. Autoimmune diseases are observed mainly in patients with a CD4 cell count of Ͼ200. In parallel with the progression of disease and lymphopenia, it may be possible to detect autoantibodies to HLA molecules and other surface markers of CD4 T cells or directed toward a number of regulatory molecules of the immune system. <ref type="bibr" target="#b137">138</ref> Structural homologies of HIV-1 env products to functional molecules involved in the control of self-tolerance could lead to the emergence of autoreactivity, through molecular mimicry mechanisms inducing dysregulation leading to autoimmune response. However, the autoimmune process may also be induced nonspecifically via bystander stimulation. <ref type="bibr" target="#b42">43</ref> In addition, the restoration of immune competence following highly active antiretroviral therapy (HAART) may favor resurgence of autoimmune diseases. <ref type="bibr" target="#b127">128,</ref><ref type="bibr" target="#b137">138</ref> Inclusion-Body Myositis. A myopathy in every respect similar to inclusion-body myositis (IBM) is observed in rare patients infected by HIV-1 or HTLV-1 (human T-cell leukemia virus type 1). <ref type="bibr" target="#b40">41</ref> Muscle biopsy shows both PM-like endomysial inflammation with MHC-I/CD8 complex and degenerating fea-tures including fiber atrophy, red-rimmed vacuoles, amyloid deposits, and eosinophilic inclusions. Retroviral antigens have been detected only on endomysial macrophages but not within the muscle fibers, indicating that retroviruses do not directly infect the muscle but trigger an immune response identical to that occurring in sporadic IBM. <ref type="bibr" target="#b41">42</ref> Nemaline Myopathy. A structural myopathy similar to nemaline (rod) myopathy of adult onset has also been described in patients who developed painless, progressive muscle weakness and wasting, and elevated serum CK levels, at an early stage of the disease. <ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b64">65</ref> Muscle biopsy disclosed prominent, randomly distributed atrophic type 1 fibers with numerous intracytoplasmic rod bodies in the centers of the fibers, corresponding to nemaline rods at electron microscopy. Necrotic fibers and inflammatory infiltrates were usually not found. Some patients had monoclonal gammopathy in association with nemaline myopathy. <ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b98">99</ref> Despite the absence of muscle inflammation, positive responses to prednisone therapy have been observed, suggesting an autoimmune mechanism for the myopathy.</p><p>Diffuse Infiltrative Lymphocytosis Syndrome. Diffuse infiltrative lymphocytosis syndrome (DILS) is a rare condition in HIV-infected patients, characterized by persistent CD8 hyperlymphocytosis and multivisceral CD8 T-cell infiltration, <ref type="bibr" target="#b81">82</ref> reflecting a particularly strong host response to HIV infection. <ref type="bibr" target="#b82">83</ref> DILS usually presents as painless parotid enlargement, accompanied by sicca syndrome in 60% of patients. <ref type="bibr" target="#b114">115</ref> Extraglandular complications of DILS include facial palsy, peripheral neuropathy, polymyositis, lymphocytic interstitial pneumonitis, renal tubular acidosis, lymphocytic hepatitis, and lymphoma. <ref type="bibr" target="#b101">102,</ref><ref type="bibr" target="#b114">115</ref> In DILS, muscle lymphocytic infiltration (Fig. <ref type="figure" target="#fig_0">1C and D</ref>) is usually found in the setting of peripheral neuropathy, <ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b101">102</ref> but a recent study reported an unexpectedly high prevalence of DILS in HIV-infected patients with inflammatory myopathy. <ref type="bibr" target="#b83">84</ref> Diagnostic criteria are: (1) HIV infection assessed by enzymelinked immunoassay and confirmatory Western blot analysis; (2) circulating CD8 hyperlymphocytosis at Ͼ1000/mm 3 ; and (3) histological confirmation of CD8 T-cell infiltration in three different organs or tissues. <ref type="bibr" target="#b101">102</ref> Minor salivary gland biopsy and gallium-67 scintigraphy are of major diagnostic help when DILS is suspected. In particular, patients taking protease inhibitors may develop parotid lipomatosis <ref type="bibr" target="#b106">107</ref> that gallium scans can distinguish from DILS. <ref type="bibr" target="#b114">115</ref> Treatment of DILS combines antiretroviral therapy and steroids. Antiretroviral therapy may be effective in treating glandular swelling, sicca syndrome, and neuropathy. <ref type="bibr" target="#b101">102,</ref><ref type="bibr" target="#b114">115</ref> Corticosteroids (up to 60 mg/day of prednisone) are effective in treating life-threatening DILS manifestations, particularly lymphocytic interstitial pneumonitis or rapidly progressive neuromuscular complications. <ref type="bibr" target="#b101">102,</ref><ref type="bibr" target="#b114">115</ref> HIV-Wasting Syndrome. Cachexia is frequently observed in patients with AIDS, especially in sub-Saharan Africa where it is called "slim disease." <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b69">70</ref> In Western countries, a condition known as the HIVwasting syndrome has been defined more precisely by criteria of the Centers for Disease Control (CDC). The syndrome combines involuntary weight loss (Ͼ10% of baseline body weight) plus either chronic diarrhea (for 30 days or longer) or chronic weakness and documented fever (for 30 days or longer), in the absence of a concurrent illness or condition other than HIV infection that could explain the findings. Weight loss and decreased lean body mass (LBM) are independent predictors of increased mortality and morbidity in HIV-infected patients. <ref type="bibr" target="#b69">70</ref> Although surveillance data by the CDC suggest that incidence of new wasting has declined in proportion to opportunistic infections, there is accumulating evidence that loss of weight and LBM is common in HIVinfected patients, even in populations with widespread access to HAART. <ref type="bibr" target="#b69">70</ref> Classic wasting with generalized weight loss must be clinically distinguished from changes in fat distribution, also termed lipodystrophy. Wasting may be more likely to occur in the context of virological or immunological failure, infection, diarrhea, or anorexia, unlike the lipodystrophy that occurs in patients with robust responses to antiretroviral therapy. It is also critical to distinguish wasting syndrome from the rapid weight loss often observed in lactic acidosis. <ref type="bibr" target="#b69">70</ref> In patients with HIV-wasting syndrome, muscle biopsy may show diffuse atrophy, or type II atrophy (Fig. <ref type="figure" target="#fig_0">1E and F</ref>), mild neurogenic atrophy, or thickfilament loss, without conspicuous inflammation, as in cachectic myopathies of other causes. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b99">100</ref> In a few patients classified as having wasting syndrome, muscle biopsy may disclose inflammatory changes including PM, necrotizing arteritis, and microvasculitis. <ref type="bibr" target="#b99">100</ref> Among a variety of possible causes of HIVwasting syndrome, one attractive hypothesis involves the proinflammatory cytokines interleukin (IL)-1␤ and tumor necrosis factor (TNF)-␣, two molecules abundantly produced by HIV-infected monocytes/ macrophages, which can induce cachexia in animal models. <ref type="bibr" target="#b10">11</ref> The ubiquitin-ATP-dependent proteolytic system was shown to be activated in muscle from cachectic AIDS patients, possibly in response to changes in circulating cytokines, and this could be at the origin of skeletal muscle wasting. <ref type="bibr" target="#b89">90</ref> Another mechanism involves increased expression of the negative regulator of skeletal muscle growth myostatin. <ref type="bibr" target="#b65">66</ref> Vasculitic Processes. A wide range of inflammatory vascular diseases including necrotizing vasculitis, resembling polyarteritis nodosa, Henoch-Scho ¨nlein purpura, hypersensitivity vasculitis, cryoglobulinemic vasculitis, and mononuclear small-vessel vasculitis, may occur in HIV-infected individuals. <ref type="bibr" target="#b56">57</ref> Vascular inflammation appears to be multifactorial and may result from HIV-induced immunological abnormalities and exposure to a variety of xenoantigens such as HIV itself, <ref type="bibr" target="#b59">60</ref> other infectious agents, and drugs. Vasculitis may seldom present as a genuine acquired myopathy with proximal limb weakness, increased serum CK levels, and myopathic EMG. <ref type="bibr" target="#b52">53</ref> However, muscle necrotizing vasculitis is most often observed in patients with peripheral neuropathy. <ref type="bibr" target="#b18">19</ref> Vasculitic neuropathy usually presents as a distal symmetric polyneuropathy with weight loss, myalgias, weakness, and leg tenderness, and less often as asymmetric polyneuropathy or true mononeuropathy multiplex. <ref type="bibr" target="#b56">57</ref> In case of necrotizing vasculitis, disease course is usually monophasic without relapses and remissions. <ref type="bibr" target="#b18">19</ref> Treatment of HIV-related vasculitis is not clearly defined, but usually combines antiretroviral drugs and immunomodulatory agents, including intravenous immunoglobulins. Corticosteroids may be extremely effective. Cytotoxic agents commonly used in the treatment of arteritis are regarded as contraindicated in immunocompromised patients. So, by analogy with hepatitis B-related polyarteritis nodosa, a strategy combining antiviral treatments and plasma exchanges has been proposed. This strategy seems effective and does not jeopardize the outcome of AIDS, as could occur with cytotoxic agents. <ref type="bibr" target="#b70">71</ref> On the fringe of clinically overt full-blown vasculitis, changes restricted to the microcirculation, including microvasculitis, noninflammatory microangiopathy, and perivascular iron-pigment deposits, are commonly observed in muscle biopsies from HIV-infected patients. <ref type="bibr" target="#b60">61</ref> Microvascular inflammation is mainly found at the level of postcapillary venules. It may be asymptomatic, and is probably more pronounced at early stages of the disease. <ref type="bibr" target="#b34">35</ref> Hemosiderin deposits may also be observed in the lower limbs, particularly at advanced stages of HIV infection. <ref type="bibr" target="#b60">61</ref> The finding is not specific and it may be observed in other immunological disorders, in diabetes mellitus, or in infection by hepatitis C virus.</p><p>Myasthenic Syndromes and Chronic Fatigue. Myasthenia gravis (MG) has been reported very occasionally in HIV-infected patients, most often at early stages of disease, and can be the presenting manifestation. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b129">130,</ref><ref type="bibr" target="#b133">134</ref> The diagnosis is assessed by the edrophonium test and electrophysiological study. HIVassociated MG is not always associated with positive detection of antibodies to acetylcholine receptors. In addition, it tends to occur as a transient phenomenon, fading with immunodepression. <ref type="bibr" target="#b4">5</ref> Treatment of HIV-associated MG is based on antiretroviral drugs, combined, if necessary, with pyridostigmine, prednisone, or intravenous immunoglobulin. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b128">129</ref> A unique case of MG occurring 3 weeks after introduction of ritonavir has been reported, suggesting that this drug should be avoided in HIV-infected MG patients. <ref type="bibr" target="#b116">117</ref> In addition, positive detection of circulating antibodies to acetylcholine receptors in patients with HIV-associated chronic fatigue could represent a predictive factor for a positive response to pyridostigmine therapy, in spite of the absence of definite myasthenia. <ref type="bibr" target="#b40">41</ref> More generally, fatigue is a commonly reported symptom in HIV-infected patients that may correlate positively with clinical AIDS, depression, and anemia, but not with viral load or CD4 ϩ cell count. <ref type="bibr" target="#b129">130</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MUSCLE COMPLICATION OF ANTIRETROVIRAL THERAPY</head><p>Zidovudine and Other NRTI Myopathies. Antiretroviral drugs mainly include NRTIs: zidovudine (AZT), stavudine (d4T), didanosine (ddI), zalcidabine (ddC), and lamivudine (3TC); non-nucleoside-analogue reverse-transcriptase inhibitors (NNRTIs; nevirapine, delaviridine, efavirenz); and protease inhibitors (PIs; saquinavir, ritonavir, indinavir, nelfinavir, amprenavir). Nucleoside analogues act in their triphosphorylated form through competition with the natural substrates of both HIV reverse transcriptase and ␥DNA polymerase, an enzyme involved in mitochondrial DNA (mtDNA) replication. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b88">89</ref> Some NRTIs, such as zidovudine, stavudine, and fialuridine, are preferentially phosphorylated in replicating cells; others, such as didanosine, zalcidabine, and lamivudine, are replicated in resting cells. <ref type="bibr" target="#b46">47</ref> Phosphorylation of each NRTI may be selectively achieved by definite cellular thymidine-kinase isoforms, the expression of which could vary from one tissue to another, thus possibly explaining the remarkable tissue selectivity of NRTI-induced tissue toxicity. <ref type="bibr" target="#b88">89</ref> Until now, zidovudine has been the main NRTI causing a mitochondrial myopathy in HIVinfected patients. <ref type="bibr" target="#b22">23</ref> Zidovudine myopathy is a reversible toxic mitochondrial myopathy occurring in patients who have received high cumulative doses of the drug. <ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b95">96</ref> Clinically, it mimics HIV-associated PM. Histologically, it is characterized by the presence of "AZT fibers," a term coined by Dalakas to designate atrophic ragged-red fibers with marked myofibrillar alterations, including thick myofilament loss and cytoplasmic-body formation (Fig. <ref type="figure" target="#fig_1">2</ref>). <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b66">67,</ref><ref type="bibr" target="#b95">96</ref> All currently available tests for the detection of mitochondrial diseases are positive in patients with zidovudine myopathy, among them: (1) respiratory chain dysfunction assessed by biochemical assays on muscle homogenates 96 ; (2) partial deficiency in cytochrome c oxidase (COX) activity (complex IV of the respiratory chain) assessed by histoenzymology (Fig. <ref type="figure" target="#fig_1">2C and D</ref>) <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32</ref> ; and (3) a high lactate:pyruvate ratio in blood. <ref type="bibr" target="#b32">33</ref> Patients with zidovudine myopathy consistently show marked depletion of their mtDNA ("mtDNA-depleting myopathy"). <ref type="bibr" target="#b2">3</ref> Muscle mtDNA depletion in zidovudine-treated HIV-infected patients was found to be more marked in patients who had either weakness, myalgia, increased serum CK levels, or ragged-red fibers. <ref type="bibr" target="#b25">26</ref> Several lines of evidence have confirmed that AZT induces mitochondrial dysfunction. First, experimentally, it was shown that AZT affects the oxidation-phosphorylation coupling and the activity of complex I and III of the respiratory chain of muscle mitochondria. <ref type="bibr" target="#b84">85</ref> Second, exposure of cultured human myotubes to AZT induces destructive changes in the mitochondria. <ref type="bibr" target="#b121">122</ref> Third, in vivo 31 P-magnetic resonance spectroscopy showed that AZT decreases the maximal work output and the maximal rate of muscle ATP synthesis in treated patients. <ref type="bibr" target="#b125">126</ref> Oxidative stress occurs in tissues of HIV-infected patients. Micronutrient deficiencies have long been recognized in HIV infection and involve vitamins and trace elements such as zinc, iron, and selenium. Selenium is a component of glutathione peroxidase, an enzyme having a major function in the removal of reactive oxygen species from cells and tissues. Selenium-deficient patients can develop a congestive cardiomyopathy or skeletal muscle involvement, manifested by pain and proximal weakness. <ref type="bibr" target="#b28">29</ref> Muscle involvement in HIV-infected patients is associated with marked selenium deficiency. <ref type="bibr" target="#b29">30</ref> In the case of zidovudine administration, selenium deficiency could potentiate the mitochondrial toxicity of zidovudine by allowing an increased formation of reactive oxygen species. Accordingly, dietary supplements with antioxidant vitamins C and E at supranu-tritional doses have been proposed to protect skeletal muscle mitochondria against oxidative damage caused by AZT. <ref type="bibr" target="#b47">48</ref> The validity of zidovudine myopathy has been disputed repeatedly. <ref type="bibr" target="#b122">123,</ref><ref type="bibr" target="#b123">124,</ref><ref type="bibr" target="#b135">136</ref> Ragged-red fibers may be rare in some patients and they usually combine mitochondrial accumulation with myofibrillar loss, which may hinder their recognition. In addition, in a number of patients, mitochondrial changes are mixed with inflammatory changes, and, on some occasions, the polymyositic process overwhelms zidovudine myopathy. Muscle biopsy from patients with muscle symptoms receiving zidovudine may show no abnormality and may lack the typical fea-tures of zidovudine myopathy if one excludes partial COX deficiency. Such a deficiency is constantly observed in our experience and represents a valuable sign in young patients. <ref type="bibr" target="#b31">32</ref> In addition, myopathologic abnormalities very similar to those observed in zidovudine myopathy have been reported in a patient treated with ribavirin and interferon-␣. <ref type="bibr" target="#b3">4</ref> Lactic Acidosis, Hepatic Steatosis, and Myopathy. A life-threatening syndrome with severe hepatic steatosis, lactic acidosis, pancreatitis, and mitochondrial myopathy with lipid accumulation, resembling Reye's syndrome, has been described in patients taking stavudine in association with another nucleoside analogue and a PI. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b97">98</ref> Early detection of this syndrome may be ensured by close monitoring of liver and muscle enzymes in serum and lactate level in blood, <ref type="bibr" target="#b41">42</ref> and fatty infiltration of liver can be detected by computed tomography. <ref type="bibr" target="#b97">98</ref> Selective inhibition of DNA polymerase-␥ by nucleoside analogues leads to depletion of mtDNA and impairment of oxidative phosphorylation, and could be at the origin of this syndrome. <ref type="bibr" target="#b97">98</ref> Recently, it was shown that mtDNA depletion could be detected in patients with symptomatic nucleoside-related hyperlactatemia by evaluating the ratio of mitochondrial to nuclear DNA in peripheral blood lymphocytes. <ref type="bibr" target="#b39">40</ref> In addition, in patients followed longitudinally, the decline in mitochondrial DNA preceded the increase in venous lactate levels, <ref type="bibr" target="#b39">40</ref> suggesting that this procedure may be appropriate for monitoring patients receiving HAART.</p><p>HIV-Associated Lipodystrophy Syndrome. A syndrome called HIV-associated lipodystrophy syndrome has been recognized on an increasing basis since 1998 in HIV-1-infected individuals, usually treated with HAART. <ref type="bibr" target="#b24">25</ref> The syndrome consists of a combination of metabolic abnormalities (hyperlipidemia and insulin resistance) and morphological changes (central fat accumulation and peripheral fat atrophy). <ref type="bibr" target="#b17">18</ref> At least one physical abnormality is detected in about 50% of patients after 12-18 months of therapy. <ref type="bibr" target="#b23">24</ref> Lipodystrophy is independent of plasma HIV load. <ref type="bibr" target="#b23">24</ref> Although duration of antiretroviral therapy is a recognized risk factor, lipodystrophy can occur in recently infected patients receiving HAART. <ref type="bibr" target="#b96">97</ref> When muscle biopsy is performed for a reason unrelated to lipodystrophy, it may show various degrees of lipid accumulation, indicating disturbances of lipid metabolism. Increased lipid content in muscle may be detected by 1 H-magnetic resonance spectroscopy <ref type="bibr" target="#b54">55</ref> and computed tomography. <ref type="bibr" target="#b131">132</ref> The picture of lipodystrophy as a multifactorial condition is emerging. It is likely that PIs cause fat accumulation (increased visceral abdominal fat, breast hypertrophy, and buffalo hump), hyperlipidemia (increased total cholesterol and triglycerides), and insulin resistance (increased circulating levels of insulin and C-peptide, glucose intolerance/type 2 diabetes mellitus), whereas NRTIs contribute to lipoatrophy, possibly with HIV infection itself, and to other manifestations often described in affected patients, including lactic acidemia, fatty liver, weight loss, nausea, and fatigue. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b78">79,</ref><ref type="bibr" target="#b102">103,</ref><ref type="bibr" target="#b105">106</ref> The mechanisms of PI-induced metabolic abnormalities are complex. <ref type="bibr" target="#b78">79</ref> First, PIs inhibit proteases that degrade transcription factors crucially involved in lipid homeostasis, called nuclear sterol regulatory element binding proteins (nSREBPs). Subsequent accumulation of these factors results in increased fatty acid and cholesterol hepatic biosynthesis, and decreased leptin expression in adipose tissue at the origin of both lipodystrophy and insulin resistance. Second, PIs also suppress proteasome-mediated breakdown of apolipoprotein B, which results in overproduction of triglyceride-rich lipoproteins. Third, in addition, PIs directly inhibit GLUT-4, a glucose transporter that mediates insulin-stimulated cellular uptake of glucose, in fat and muscle, thus directly contributing to insulin resistance. <ref type="bibr" target="#b102">103,</ref><ref type="bibr" target="#b105">106</ref> Although firm conclusions regarding mechanisms of the clinical syndrome are still lacking, resemblance between HAART-related lipodystrophy and multiple symmetrical lipomatosis syndrome (Launois-Bensaude or Madelung's syndrome), which is associated with mtDNA point mutations or deletions impairing COX activity, <ref type="bibr" target="#b19">20</ref> suggests that NRTIs add their mitochondrial toxic effects to PI-induced metabolic disturbances.</p><p>HAART-Related Immune Restoration Inflammatory Syndrome. Immunodeficient HIV patients treated by HAART may develop paradoxical inflammatory responses due to the reconstitution of the previously incompetent specific immunity, a phenomenon termed immune restoration inflammatory syndrome (IRIS). <ref type="bibr" target="#b127">128</ref> HAART-related IRIS encompasses: (1) overt infectious inflammatory processes secondary to silent opportunistic pathogens, including tuberculosis and other nontuberculosis mycobacterial infections, cytomegalovirus (CMV) retinitis, and herpes zoster and herpes simplex reactivation; (2) human herpesvirus (HHV)-8 -associated diseases, including Castleman's disease and Kaposi's sarcoma; and (3) noninfectious inflammatory diseases, including autoimmune diseases, allergic reactions, sarcoidosis, and induction of atherogenic chronic inflammation. <ref type="bibr" target="#b115">116,</ref><ref type="bibr" target="#b127">128</ref> Muscle involvement in the setting of IRIS consists of polymyositis, <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b120">121</ref> which may masquerade as antiretroviral toxicity. <ref type="bibr" target="#b113">114</ref> Although there have been few reported cases, muscle biopsy findings and treatment of IRIS polymyositis seem similar to those of classic HIV polymyositis (Fig. <ref type="figure" target="#fig_2">3A-D</ref>). The risk of developing IRIS seems linked to various putative risk factors: (1) duration of immunodeficiency; (2) extent of immunodeficiency;</p><p>(3) velocity and extent of immune reconstitution; (4) specific pattern of immune reconstitution under HAART, including immune reconstitution without complete suppression of HIV replication, high levels of circulating CD8 T cells, persisting polyclonal hyper-gammaglobulinemia, increase in (CMV-) specific IgG antibodies, development of specific delayed-type hypersensitivity, and high levels of IL-6 and soluble IL-6 receptor; and (5) genetic susceptibility, including distinct HLA haplotypes and polymorphism in TNF-␣, IL-6, and IL-12 genes. <ref type="bibr" target="#b127">128</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OPPORTUNISTIC INFECTIONS AND TUMORS OF MUSCLE</head><p>Opportunistic infections of the skeletal muscle are seldom recognized. They mainly include focal pyo-genic infection (so-called pyomyositis), usually due to Staphylococcus aureus, 10 but infections by CMV, Cryptococcus neoformans, Mycobacterium avium intracellulare, microsporidiosis, and Toxoplasma gondii have been also reported. <ref type="bibr" target="#b61">62</ref> Muscle toxoplasmosis is found in profoundly immunodepressed patients, typically presenting with a painful subacute myopathy and concurrent multivisceral toxoplasmosis. <ref type="bibr" target="#b55">56,</ref><ref type="bibr" target="#b111">112</ref> Toxoplasma cysts are mainly observed in muscle fibers at muscle biopsy, and identification of cysts as Toxoplasma may be easier by using specific antibodies or electron microscopy (Fig. <ref type="figure" target="#fig_2">3E and F</ref>). A PM-like process of unknown significance is usually associated with muscle toxoplasmosis. <ref type="bibr" target="#b111">112</ref> Treatment is based on a combination of drugs acting synergistically against T. gondii, pyrimethamine, and sulfadiazine or trisulfapyrimidines.</p><p>Extranodal non-Hodgkin's lymphoma is frequently observed in AIDS, but rarely involves muscle. Muscle involvement in non-Hodgkin's malignant lymphoma may be the presenting manifestation and become apparent by a rapidly growing muscle mass associated with fever. <ref type="bibr" target="#b37">38</ref> Typically, histopathological examination shows a lymphomatous proliferation destroying the muscle tissue, and invading the fascia and subcutaneous tissue. Magnetic resonance imaging is useful in distinguishing muscle lymphoma from other causes of limb swelling in patients with AIDS, including pyomyositis, deep vein thrombosis, focal onset of polymyositis, and even muscle involvement by Kaposi's sarcoma. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b58">59,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b126">127</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RHABDOMYOLYSIS</head><p>Rhabdomyolysis/myoglobinuria is defined by acute myofiber injury leading to release of cellular components into the blood and urine. Rhabdomyolysis is associated with myalgias, weakness, and edema, and by a marked increase of blood CK and myoglobin levels. A urinary myoglobin level of Ͼ250 g/ml results in colacolored urine. <ref type="bibr" target="#b118">119</ref> Rhabdomyolysis can occur at all stages of HIV infection and may be separated into three groups: (1) HIV-associated rhabdomyolysis, including rhabdomyolysis in primary HIV infection, recurrent rhabdomyolysis, and isolated rhabdomyolysis;</p><p>(2) drug-induced rhabdomyolysis; and (3) rhabdomyolysis at the end stage of AIDS, associated or not with opportunistic infections of muscle. <ref type="bibr" target="#b33">34</ref> Drugs implicated in rhabdomyolysis in HIV patients include didanosine, lamivudine, trimethoprim-sulfamethoxazole, ritonavir, and indinavir. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b94">95,</ref><ref type="bibr" target="#b124">125</ref> In addition, PIs may increase the concentrations of most hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins), <ref type="bibr" target="#b38">39</ref> and treatment of PI-related hyperlipidemia by statins seems associated with an increased risk of rhabdomyolysis. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b74">75,</ref><ref type="bibr" target="#b90">91,</ref><ref type="bibr" target="#b93">94</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE I (HTLV-I) MYOSITIS</head><p>Various other retroviruses, such as HTLV-I in humans, simian immunodeficiency virus (SIV) and simian retrovirus (SRV) type I in monkeys, and feline immunodeficiency virus (FIV) in cats, may cause inflammatory muscle involvement. <ref type="bibr" target="#b41">42</ref> HTLV-I-infected individuals may develop various neuro-logical disorders, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/ TSP), motor neuron disease, peripheral neuropathy, polymyositis, and IBM. <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b53">54,</ref><ref type="bibr" target="#b62">63,</ref><ref type="bibr" target="#b73">74,</ref><ref type="bibr" target="#b85">86,</ref><ref type="bibr" target="#b138">139</ref> Muscle involvement in HTLV-I-infected patients may occur alone or in association with HAM/TSP. <ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b134">135</ref> HTLV-I-related muscle involvement closely resembles that encountered in HIV patients. HTLV-I PM has a more insidious presentation, a more protracted course, and a poorer response to steroids than seronegative PM. <ref type="bibr" target="#b62">63</ref> In addition, some patients develop a chronic myopathy corresponding to IBM with proximal and distal weakness and the characteristic histological features at muscle biopsy. <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b107">108</ref> Mechanisms leading to muscle involvement during HTLV-I infection seem comparable to those implicated in HIV myopathy. Endomysial cells are mainly CD8 ϩ cytotoxic cells, surrounding and invading non-necrotic MHC-I-positive fibers. Molecular analysis has shown muscle-infiltrating T cells consisting of predominantly locally expanded clones. <ref type="bibr" target="#b117">118</ref> This suggests a T-cell-mediated MHC-Irestricted cytotoxic process, similar to that described for HIV PM. <ref type="bibr" target="#b41">42</ref> Viral genome may be seen in muscle tissue from patients with HTLV-I PM, <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b53">54,</ref><ref type="bibr" target="#b76">77,</ref><ref type="bibr" target="#b130">131</ref> with localization of viral antigens in muscle-infiltrating CD4 ϩ lymphocytes. <ref type="bibr" target="#b77">78</ref> A recent study showed the presence of both perforin-positive CD8 ϩ T cells directed toward the dominant Tax antigen and tax mRNA-positive mononuclear cells in muscle tissue from an HTLV-I-infected patient with IBM. <ref type="bibr" target="#b108">109</ref> This strongly supports the cytotoxic immune reaction model for the pathogenesis of HTLV-I-associated inflammatory myopathy. <ref type="bibr" target="#b108">109</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p>Skeletal muscle involvement in HIV-infected patients varies according to both immunological status and antiretroviral therapy. So far, the influence of HAART on muscle complications of HIV infection has not been accurately evaluated. HIV-wasting syndrome and opportunistic muscle infections are still encountered in untreated patients, particularly in migrants or in underprivileged sections of the population. In contrast, treated patients may develop inflammatory myopathy related to immune restoration or drug-induced muscle involvement. Physicians must be aware that HAART has modified but not erased muscle complications of HIV infection, and that increased life expectancy of treated patients may favor emergence of iatrogenic disorders.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>FIGURE 1. (A and B) HIV polymyositis. (A) Ubiquitous myofiber expression of MHC-I (frozen section, immunoperoxidase stain). (B) CD8 ϩ T-cell endomysial infiltration surrounding myofibers (frozen section, immunoperoxidase). (C and D) Diffuse infiltrative lymphocytosis syndrome (DILS). (C) Perivascular and interstitial CD8 ϩ T-cell infiltration (frozen section, APAAP stain). (D) Endomysial CD8 ϩ T cells in contact with myofibers (frozen section, APAAP). (E and F) Wasting syndrome. (E) Type 2 fiber atrophy (frozen sections, fast myosin heavy chain, APAAP). (F) Abnormal MHC-I expression by atrophic type 2 fibers (frozen sections, immunoperoxidase).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 2 .</head><label>2</label><figDesc>FIGURE 2. AZT myopathy. (A and B) Ragged-red fibers (AZT fibers) showing marked myofibrillar alterations (frozen sections, Masson trichrome stain). (C) Partial deficiency in cytochrome c oxidase (COX) activity. (D) At higher magnification, two COX-negative fibers [asterisk in (C)] showing normal appearance (frozen section, COX). (E) Myofilamentous degradation in AZT fibers (arrowheads) (frozen sections, ATPase 10.4). (F) Increased succinate dehydrogenase (SDH) activity indicating mitochondrial accumulation (frozen section, SDH).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 3 .</head><label>3</label><figDesc>FIGURE 3. (A-D) Muscle involvement during immune restoration syndrome. (A) Ubiquitous myofiber expression of MHC-I (frozen section, immunoperoxidase stain). (B) Scattered CD8 ϩ T cells in endomysium (paraffin section, immunoperoxidase). (C and D) Perivascular mononuclear cell infiltration with numerous CD8 ϩ T-cells (C) and rare CD138 ϩ plasma cells (D) (paraffin sections, immunoperoxidase). (E and F) Muscle toxoplasmosis. (E) A collection of bradyzoites (arrowhead) in a muscle fiber (frozen section, haematoxylin-eosin stain). (F) Immunodetection of bradyzoites (arrowhead) within a cyst by using an anti-Toxoplasma gondii antibody (frozen sections, immunoperoxidase).</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0">MUSCLE &amp; NERVE September 2005 10974598, 2005, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/mus.20338 by University Of Illinois At Urbana Champaign, Wiley Online Library on [08/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="10974598" xml:id="foot_1">, 2005, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/mus.20338 by University Of Illinois At Urbana Champaign, Wiley Online Library on [08/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Simvastatin-induced rhabdomyolysis in an HIV-infected patient with coronary artery disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Aboulafia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Johnston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Patient Care STDS</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="13" to="18" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Anders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Bogner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Goebel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Med Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="198" to="200" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arnaudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shanske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Shon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="page" from="508" to="510" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Muscle mtDNA alterations during ribavirin therapy</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bassez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Zarrouk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jardel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mallat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">250</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">203</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Transient myasthenia gravis during HIV infection</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Grissac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Degos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="914" to="916" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Peripheral neuropathies in HIVinfected patients in the era of HAART</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Pathol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="223" to="228" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Myositis and acquired immunodeficiency syndrome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Turok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Jaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Sigh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="749" to="751" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Gronseth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Leforce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mcvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Butzin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="167" to="171" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Primary muscle lymphoma</title>
		<author>
			<persName><forename type="first">I</forename><surname>Beggs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Radiol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="203" to="212" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">HIV infection in African patients with tropical pyomyositis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Be ´lec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Costanzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Georges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">234</biblScope>
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Differential elevation of circulating interleukin-1␤, tumor necrosis factor ␣, and interleukin 6 in AIDS-associated cachectic states</title>
		<author>
			<persName><forename type="first">L</forename><surname>Be ´lec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Meillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vohito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hernvann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Diag Lab Immunol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="117" to="120" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The HIVwasting syndrome</title>
		<author>
			<persName><forename type="first">L</forename><surname>Be ´lec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Costanzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="856" to="857" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Benbrik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bonavaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ammi-Said</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frisdal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="19" to="25" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir</title>
		<author>
			<persName><forename type="first">O</forename><surname>Benveniste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Longuet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Duval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Moing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Leport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vilde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1180" to="1181" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients</title>
		<author>
			<persName><forename type="first">O</forename><surname>Benveniste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cherin</forename><forename type="middle">P</forename><surname>Maisonobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Merat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chosidow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mouthon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="3521" to="3529" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions</title>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kerschensteiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Misgeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="5943" to="5951" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8 ϩ T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iglesias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dornmair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="1863" to="1868" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">HIV-associated lipodystrophy syndrome: description and pathogenesis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Bodasing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="149" to="154" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Retroviral-associated vasculitis of the nervous system</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Brannagan</surname></persName>
		</author>
		<author>
			<persName><surname>Iii</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol Clin</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="927" to="944" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Brinkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Smeitink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Romijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="1112" to="1115" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">HTLV-1 polymyositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Caldwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Breuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Swash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="151" to="154" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Polymyositis associated with HIV infection during immune restoration induced by highly active anti-retroviral therapy</title>
		<author>
			<persName><forename type="first">L</forename><surname>Calza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Manfredi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Colangeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Freo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chiodo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="651" to="652" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Adverse effects of antiretroviral therapy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page" from="1423" to="1430" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="F25" to="F32" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Samaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Burton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Freund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Chisholm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="F51" to="F58" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction</title>
		<author>
			<persName><forename type="first">J</forename><surname>Casademont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barrientos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Estivill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Urbano</forename><forename type="middle">-</forename><surname>Marquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1357" to="1364" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gutierrez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page">505</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Benbrik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaeffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="431" to="436" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Skeletal muscle disorders associated with selenium deficiency in humans</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Bignani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="662" to="668" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiency</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Dubreuil-Lemaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Larcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="386" to="389" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="357" to="363" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Monnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="561" to="565" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Blood lactate/pyruvate ratio as a non invasive test for the diagnosis of zidovudine myopathy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Monnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mouchet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lefaucheur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Dubreuil-Lemaire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="583" to="586" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Acute rhabdomyolysis in patients infected by human immunodeficiency virus</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chariot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ruet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1692" to="1696" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The spectrum of changes on 20 nerve biopsies in patients with HIV infection</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Chaunu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ratinahirana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raphael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Henin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Brun-Vezinet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="452" to="459" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth</title>
		<author>
			<persName><forename type="first">B</forename><surname>Chazaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lafuste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bassez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Rimaniol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Poron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="1133" to="1143" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis due to probable interaction between simvastatin and ritonavir</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Pearson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Health Syst Pharm</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="728" to="730" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Muscle lymphoma in patients with AIDS: a diagnostic problem with pyomyositis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Chevalier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Amoura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Viard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Souissi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="426" to="427" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Chuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Penzak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Saf</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="5" to="17" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Cote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">L</forename><surname>Brumme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Craib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wynhoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ting</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page" from="811" to="820" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Cupler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Otero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hench</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luciano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1186" to="1188" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Virus-related muscle diseases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">basic and clinical</title>
				<editor>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Engel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Franzini-Armstrong</surname></persName>
		</editor>
		<editor>
			<persName><surname>Myology</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>McGraw-Hill</publisher>
			<date type="published" when="2004">2004</date>
			<biblScope unit="page" from="1389" to="1417" />
		</imprint>
	</monogr>
	<note>3rd ed</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="page" from="971" to="982" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mitochondrial myopathy caused by long-term zidovudine therapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Illa</forename><forename type="middle">I</forename><surname>Pezeschkpour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Laukaitis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="1098" to="1105" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Progressive nemaline (rod) myopathy associated with HIV infection</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Pezeshkpour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Flaherty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="page" from="1602" to="1603" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Polymyositis associated with AIDS retrovirus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Pezeshkpour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gravell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sever</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">256</biblScope>
			<biblScope unit="page" from="2381" to="2383" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Peripheral neuropathy and antiretroviral drugs</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Peripher Nerv Syst</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="14" to="20" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>De La Asuncion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Del Olmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sastre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Millan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pellin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">V</forename><surname>Pallardo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="4" to="9" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Douen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Pringle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guberman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="896" to="900" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Progressive nemaline (rod) myopathy as a presentation of human immunodeficiency virus infection</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Dwyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page">440</biblScope>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">HTLV-Iassociated myelopathy and polymyositis in a US native</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Harrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1572" to="1575" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Feinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Spiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Weidenheim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="529" to="531" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature</title>
		<author>
			<persName><forename type="first">C</forename><surname>Font</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Miro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Masanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Coll-Vinent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Casademont</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="796" to="799" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Gabbai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Nobrega</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="923" to="930" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Samaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Kraegen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="3163" to="3169" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baudrimont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lionnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Salord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Duvivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Michon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="535" to="542" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Be ´lec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Lescs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1164" to="1174" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chretien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Delfau-Larue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moulignier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Roulland-Dussoix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1041" to="1044" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Involvement of skeletal muscle</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Goebel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Atlas of the neuropathology of HIV infection</title>
				<editor>
			<persName><surname>Gray</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="1993">1993</date>
			<biblScope unit="page" from="261" to="283" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Necrotizing vasculitis and HIV replication in peripheral nerves</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lebargy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gaulard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Bernaudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="685" to="686" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Iron pigment deposits, small vessel vasculitis and erythrophagocytosis in the muscle of human immunodeficiency virus-infected patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baudrimont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Roullet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Poirier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1187" to="1194" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Skeletal muscle involvement in HIV-infected patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathol Appl Neurobiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="232" to="237" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">HTLV-1 associated polymyositis in Jamaica</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Smikle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Simeon</forename><forename type="middle">D</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="101" to="104" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engelhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pongratz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2905" to="2910" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Subacute structural myopathy associated with human immunodeficiency virus infection</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Gonzales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Olney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Greco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Mcquinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="585" to="587" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Gonzalez-Cadavid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yarasheski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sinha-Hikim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ezzat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="14938" to="14943" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine myopathy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Masanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Casademont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fernandez-Sola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Urbano-Marquez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="206" to="214" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">HIV encephalitis-like multinucleated giant cells in a nodal lymphoma in AIDS</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gaulard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Bezu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poirier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="402" to="407" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">F</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Scaravilli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathology of AIDS</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="245" to="266" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note>Brain</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss. Weight loss and wasting in patients infected with human immunodeficiency virus</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grinspoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mulligan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="S69" to="S78" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Management of virus-induced systemic vasculitis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Guillevin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Rheumatol Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="60" to="66" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Kaposi&apos;s sarcoma infiltrating skeletal muscle</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Haddow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Buckingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex Transm Infect</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="464" to="465" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Hamers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Downs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">HIV in central and Eastern Europe</title>
				<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="1035" to="1044" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Clinical spectrum of HTLV-I in south Florida</title>
		<author>
			<persName><surname>Harrington Wj</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ucar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Snodgrass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sheremata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cabral</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acq Immune Defic Syndr Hum Retrovirol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="466" to="473" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Simvastatinnelfinavir interaction implicated in rhabdomyolysis and death</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Hare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grunfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Lampiris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="e111" to="e112" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Myogenic satellite cells: physiology to molecular biology</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Hawke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Garry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="534" to="551" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kashio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Izumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Izumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="854" to="858" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4ϩ lymphocytes</title>
		<author>
			<persName><forename type="first">I</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rosales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="358" to="361" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">HIV protease inhibitors and atherosclerosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Hui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="317" to="318" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Illa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="474" to="481" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">The changing picture of the HIV/AIDS epidemic</title>
		<author>
			<persName><forename type="first">G</forename><surname>Ippolito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Galati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Serraino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Girardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann NY Acad Sci</title>
		<imprint>
			<biblScope unit="volume">946</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5</title>
		<author>
			<persName><forename type="first">S</forename><surname>Itescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Brancato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Buxbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Gregersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Rizk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Croxson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="3" to="10" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response</title>
		<author>
			<persName><forename type="first">S</forename><surname>Itescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dalton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Winchester</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="2216" to="2225" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Dimachkie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Reveille</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="172" to="178" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lamperth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dagani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ferrari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="742" to="751" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Neurological manifestations in HTLV-I-infected blood donors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Mendonca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Serpa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Nascimento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Q</forename><surname>Araujo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">214</biblScope>
			<biblScope unit="page" from="49" to="56" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Illa</forename><forename type="middle">I</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="643" to="649" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lamperth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="408" to="413" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Mitochondrial toxicity of antiviral drugs</title>
		<author>
			<persName><forename type="first">W</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="417" to="422" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Llovera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Garcia-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Lopez-Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="69" to="73" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mah Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Patient Care STDS</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="207" to="210" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kastrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Esser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hengge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hufnagel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="376" to="380" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Inflammatory myopathies: clinical, diagnostic and therapeutic aspects</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="407" to="425" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Mastroianni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ettorre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Forcina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lichtner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Corpolongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Coletta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="820" to="821" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis in antiretroviral therapy with lamivudin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mendila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dtsch Med Wochenschr</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="1003" to="1006" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baudrimont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bonne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Degoul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Marsac</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="606" to="614" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Lipodystrophy following antiretroviral therapy of primary HIV infection</title>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Emery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2406" to="2407" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kovacs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="192" to="196" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Distinct light microscopic changes in HIV-associated nemaline myopathy</title>
		<author>
			<persName><forename type="first">O</forename><surname>Miro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pedrol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="241" to="242" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Skeletal muscle studies in patients with HIV-related wasting syndrome</title>
		<author>
			<persName><forename type="first">O</forename><surname>Miro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pedrol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cebrian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Masanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Casademont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mallolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="153" to="159" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">HTLV-1 and polymyositis in Jamaica</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rodgers-Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Char</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1184" to="1187" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Moulignier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baudrimont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pialoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Belec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Polivka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="438" to="445" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">The mechanism of insulin resistance caused by HIV protease inhibitor therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Murata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Hruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mueckler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="20251" to="20254" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis specific antibodies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Naragaju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Loeffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Rochon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="9209" to="9214" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Nishio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Miyasaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kohsaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="4051" to="4058" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">The HIV protease inhibitor indinavir decreases insulin-and contraction-stimulated glucose transport in skeletal muscle</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Yarasheski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kawanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Holloszy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1397" to="1401" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Olive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salavert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manriquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Clotet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moragas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page">749</biblScope>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ozden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gessain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="510" to="514" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Direct evidence for a chronic CD8ϩ-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ozden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cochet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gessain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pique</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="10320" to="10327" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Panegyres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Papadimitriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hollingworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Kakulas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="649" to="655" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Pavlath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="42" to="50" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Plonquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bassez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Farcet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gherardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="761" to="765" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Feline immunodeficiency virus associated myopathy in the adult cat</title>
		<author>
			<persName><forename type="first">M</forename><surname>Podell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Shelton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1680" to="1685" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Polymyositis masquerading as mitochondrial toxicity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Prime</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Pakianathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Holton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Scaravilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex Transm Infect</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="417" to="418" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">The changing spectrum of rheumatic disease in human immunodeficiency virus infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Reveille</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="147" to="166" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Opportunistic infections shortly after beginning highly active antiretroviral therapy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez-Rosado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Lahoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antivir Ther</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="229" to="231" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Ritonavir-associated myasthenia gravis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Saadat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kaminski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="680" to="681" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Molecular analysis of T cell clonotypes in muscleinfiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Izumo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Usuku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Bangham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="1231" to="1241" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Sieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Penn</forename><forename type="middle">As</forename><surname>Myoglobinuria</surname></persName>
		</author>
		<title level="m">basic and clinical</title>
				<editor>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Engel</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C</forename><surname>Franzini-Armstrong</surname></persName>
		</editor>
		<editor>
			<persName><surname>Myology</surname></persName>
		</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>McGraw-Hill</publisher>
			<date type="published" when="2004">2004</date>
			<biblScope unit="page" from="1677" to="1692" />
		</imprint>
	</monogr>
	<note>3rd ed</note>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids in skeletal muscle in patients with myopathy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Peress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Nuovo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="369" to="375" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Monsuez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Minozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Passeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vittecoq</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="510" to="512" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Effect of l-carnitine on the zidovudine-induced destruction of human myotubes. Part I: l-carnitine prevents the myotoxicity of AZT in vitro</title>
		<author>
			<persName><forename type="first">Semino-Mora</forename><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Leon-Monzon Me</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="102" to="112" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Citak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Godfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Godbold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Wolfe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="971" to="976" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Analysis of myopathy in a placebo-controlled zidovudine trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Slasor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dafni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Fischl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="382" to="385" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Rhabdomyolysis in human immunodeficiency virus-positive patients taking trimethoprim-sulfamethoxazole</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Racoosin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Viraraghavan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="233" to="234" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Sinnwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Soueidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Mclaughlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="126" to="131" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Magnetic resonance imaging of pyomyositis in 43 cases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Aguilera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Radiol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="59" to="64" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Adverse events of desirable gain in immunocompetence: the immune restoration syndrome inflammatory syndromes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmun Rev</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="243" to="249" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Seronegative myasthenia gravis and human immunodeficiency virus infection: response to intravenous gamma globulin and prednisone</title>
		<author>
			<persName><forename type="first">J</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Zochodne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="254" to="256" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Adult and adolescent spectrum of HIV disease investigators. Prevalence and correlates of fatigue among persons with HIV infection</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Dworkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pain Sympt Manage</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="329" to="333" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Tangy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Vernant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Coscoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ossondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bellance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Zaninovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="454" to="460" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Torriani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hadigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grinspoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="1005" to="1010" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Polymyositis: an overdiagnosed entity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Van Der Meulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Bronner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hoogendijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Venrooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Voskuyl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="316" to="321" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Myasthenia gravis associated with dual infection of HIV and HTLV-I</title>
		<author>
			<persName><forename type="first">A</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Berger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1355" to="1356" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<monogr>
		<title level="m" type="main">Muscle infection: viral, parasitic, bacterial, and spirochetal</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Wadia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Katrak</surname></persName>
		</author>
		<editor>Shapira AHV, Griggs RC</editor>
		<imprint>
			<date type="published" when="1999">1999</date>
			<publisher>Butterworth-Heinemann</publisher>
			<biblScope unit="page" from="339" to="362" />
			<pubPlace>Stoneham, MA</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">Muscle diseases</note>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">AZT myopathy and HIV-1 polymyositis: one disease or two?</title>
		<author>
			<persName><forename type="first">K</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Demaerschalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Crukley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hammond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="390" to="393" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Recurrent myoblobinuria and HIV seropositivity: incidental or pathogenic association?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Younger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Hays</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uncini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Lovelace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="842" to="843" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Zandman-Goddard G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Schoenfeld</forename><forename type="middle">Y</forename><surname>Hiv</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmun Rev</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="329" to="337" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Zunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Alarcon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Montano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Longstreth</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Holmes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="386" to="390" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
